Letter to the editor: What about cholesterol as a novel biomarker for bladder and kidney cancer diagnosis and surveillance? In memory of my dad Sossio Mormile
- PMID: 33660453
- PMCID: PMC7940856
- DOI: 10.4111/icu.20200360
Letter to the editor: What about cholesterol as a novel biomarker for bladder and kidney cancer diagnosis and surveillance? In memory of my dad Sossio Mormile
Conflict of interest statement
The author has nothing to disclose.
References
-
- Lim J, Kang SY, Park HS. Low serum cholesterol as a risk factor for kidney and bladder cancer among Korean men: using a national cohort sample. Cancer Causes Control. 2019;30:1101–1102. - PubMed
-
- Zhou P, Li B, Liu B, Chen T, Xiao J. Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: a systematic review and meta-analysis. Clin Chim Acta. 2018;477:94–104. - PubMed
-
- Hashizume M, Mihara M. IL-6 and lipid metabolism. Inflamm Regen. 2011;31:325–333.
-
- Kamińska K, Czarnecka AM, Escudier B, Lian F, Szczylik C. Interleukin-6 as an emerging regulator of renal cell cancer. Urol Oncol. 2015;33:476–485. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
